STORM Therapeutics announces publication in nature on RNA epigenetics by founder Professor Tony Kouzarides

STORM Therapeutics today announced the publication of data in the internationally renowned scientific journal Nature linking an essential RNA-modifying enzyme to acute myeloid leukaemia (AML).

Read the press release

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 2022 Dates To be Confirmed